A Ruthenium Antimetastasis Agent Forms Specific Histone Protein Adducts in the Nucleosome Core

被引:152
作者
Wu, Bin [1 ]
Ong, Michelle S. [1 ]
Groessl, Michael [2 ]
Adhireksan, Zenita [1 ]
Hartinger, Christian G. [1 ,3 ]
Dyson, Paul J. [2 ]
Davey, Curt A.
机构
[1] Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, Singapore 637551, Singapore
[2] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland
[3] Univ Vienna, Inst Inorgan Chem, A-1090 Vienna, Austria
关键词
bioinorganic chemistry; cancer; histone binding; nucleosomes; RAPTA-C; ruthenium; ANTICANCER METALLODRUGS; MASS-SPECTROMETRY; COMPLEXES; CHROMATIN; BINDING; DNA; INHIBITION; CISPLATIN; DRUGS;
D O I
10.1002/chem.201100298
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
His-tones are not ruth-less: A ruthenium anticancer agent, RAPTA-C, was found to associate with chromatin in cancer cells and to form stable, well-defined adducts in the nucleosome core at specific histone protein sites (see picture). This illuminates the macromolecular binding properties of this antimetastasis agent and indicates potential for developing metallodrugs for site-selective targeting of chromatin. © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
页码:3562 / 3566
页数:5
相关论文
共 42 条
[1]   [Ru(η6-p-cymene)Cl2(pta)] (pta=1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane):: a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells [J].
Allardyce, CS ;
Dyson, PJ ;
Ellis, DJ ;
Heath, SL .
CHEMICAL COMMUNICATIONS, 2001, (15) :1396-1397
[2]  
Ang W. H., 2009, ANGEW CHEM, V121, P3912
[3]   Classical and non-classical ruthenium-based anticancer drugs: Towards targeted chemotherapy [J].
Ang, Wee Han ;
Dyson, Paul J. .
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2006, (20) :4003-4018
[4]   Rational Design of an Organometallic Glutathione Transferase Inhibitor [J].
Ang, Wee Han ;
Parker, Lorien J. ;
De Luca, Anastasia ;
Juillerat-Jeanneret, Lucienne ;
Morton, Craig J. ;
Lo Bello, Mario ;
Parker, Michael W. ;
Dyson, Paul J. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (21) :3854-3857
[5]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[6]  
Beckford Floyd A, 2010, Int J Inorg Chem, V2010, P1, DOI 10.1155/2010/975756
[7]   Emerging Protein Targets for Anticancer Metallodrugs: Inhibition of Thioredoxin Reductase and Cathepsin B by Antitumor Ruthenium (II)-Arene Compounds [J].
Casini, Angela ;
Gabbiani, Chiara ;
Sorrentino, Francesca ;
Rigobello, Maria Pia ;
Bindoli, Alberto ;
Geldbach, Tifimann J. ;
Marrone, Alessandro ;
Re, Nazzareno ;
Hartinger, Christian G. ;
Dyson, Paul J. ;
Messori, Luigi .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (21) :6773-6781
[8]   Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound [J].
Casini, Angela ;
Gabbiani, Chiara ;
Michelucci, Elena ;
Pieraccini, Giuseppe ;
Moneti, Gloriano ;
Dyson, Paul J. ;
Messori, Luigi .
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2009, 14 (05) :761-770
[9]   Modification and uptake of a cisplatin carbonato complex by Jurkat cells [J].
Centerwall, Corey R. ;
Tacka, Kirk A. ;
Kerwood, Deborah J. ;
Goodisman, Jerry ;
Toms, Bonnie B. ;
Dubowy, Ronald L. ;
Dabrowiak, James C. .
MOLECULAR PHARMACOLOGY, 2006, 70 (01) :348-355
[10]   A charged and contoured surface on the nucleosome regulates chromatin compaction [J].
Chodaparambil, Jayanth V. ;
Barbera, Andrew J. ;
Lu, Xu ;
Kaye, Kenneth M. ;
Hansen, Jeffrey C. ;
Luger, Karolin .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2007, 14 (11) :1105-1107